Concepedia

Matthew Agee

MA

Statistics

Publications

1

Citations

49

H-Index

1

Active since

2024

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Matthew Agee is an author at Memorial Sloan Kettering Cancer Center specializing in neuroendocrine tumor therapy, neuroendocrine tumors, and diagnostic imaging.

Publications per year

2024–2024

1

Publications

1

Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial

Salomon Tendler, Mark Dunphy, Matthew Agee et al. · The Lancet Oncology · 2024 · 49 citations · Full text

, , +16

1–1 of 1